Chromium picolinate counteracts fattening effects of diabetic drugs
People with diabetes who are overweight face an increased risk of cardiovascular disease and other complications. But some
of the most widely used anti-diabetes drugs cause weight gain. Researchers at the University of Vermont have now shown that
chromium picolinate supplementation can reduce this fattening effect.
In a clinical trial 27 people with type 2 diabetes took sulfonylurea (a commonly prescribed treatment) for 3 months. Then
some of the participants added chromium picolinate at 1000 mcg/day, the rest added a placebo. Six months later those using
the active combination had gained only a tenth of the amount of body fat as did those on the placebo; the chromium addition
also improved blood sugar control and insulin sensitivity over that of the placebo.
Despite the widely publicized scare-tactics of anti-supplement zealots, numerous studies have shown that chromium in the form
used in chromium picolinate is safe to consume at far higher doses than those used as supplements.
Link to news article:
Chromium Picolinate Reduces Weight Gain Associated with Diabetes Medication
Links to recent report on chromium safety:
New Study Published in Leading Journal Reinforces Safety of Chromax Chromium Picolinate; Data Supported UK Food Standards
Agency Confirmation of Safety
Lack of mutagenicity of chromium picolinate in the hypoxanthine phosphoribosyltransferase gene mutation assay in Chinese hamster
ovary cells.
LifeLink carries chromium picolinate in 200 mcg capsules.